Ligand Pharmaceuticals Incorporated (LGND)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 73.22 |
| Open | 74.37 |
| Bid | 79.95 x 100 |
| Ask | 80.40 x 100 |
| Day's Range | 72.95 - 81.38 |
| 52 Week Range | 49.24 - 94.57 |
| Volume | |
| Avg. Volume | 180,050 |
| Market Cap | 1.443B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 26.52 |
| EPS (TTM) | 3.03 |
| Earnings Date | Aug 06, 2024 - Aug 12, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Jul 02, 2010 |
| 1y Target Est | 116.80 |
Insider MonkeyLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2024 Earnings Call Transcript
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2024 Earnings Call Transcript May 7, 2024 Ligand Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $4.75, expectations were $1.13. LGND isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by. Our […]
ZacksEsperion (ESPR) Q1 Earnings Beat, Stock Up on Strong Revenues
Esperion's (ESPR) first-quarter earnings and sales beat estimates on the back of better-than-expected collaboration revenues.
- Zacks
Ligand (LGND) Beats Q1 Earnings, Misses Sales Estimates
Ligand Pharmaceuticals (LGND) reports mixed first-quarter results. Management reiterates the 2024 financial outlook.
© 2024 Yahoo. All rights reserved.